If you’re trying to stand out on LinkedIn, it might seem like posting about your own achievements is a smart approach. But new research from The University of Texas at Arlington suggests a different ...

LinkedIn is cracking down on AI-generated “slop” by suppressing generic posts from recommendations rather than removing them. The platform claims 94 per cent detection accuracy in early tests, but has ...

WASHINGTON, May 18 (Reuters) - U.S. President Donald Trump said on Monday that TrumpRx.gov, a government-backed website that lists discounted prescription drugs, will begin featuring generic medicines ...

HISTORIC LAUNCH TO LOWER DRUG PRICES FOR AMERICAN PATIENTS: Today, President Donald J. Trump announced an expansion of TrumpRx.gov to provide unprecedented price transparency and choice on generic ...

The era of cheap, officially approved semaglutide is finally here—in Canada, that is. The country has just become the first in North America and the first G7 nation to license a generic version of the ...

LONDON, April 23 (Reuters) - International cyber agencies on Thursday urged organisations to better defend against covert networks used by China-linked hackers to conceal malicious ‌cyber activity, ...

Abstract: This work introduces new hardware merge sort devices, which merge multiple sorted input lists of numeric values into a single sorted output list of those values in a fast and efficient ...

Iran-affiliated cyber actors are targeting internet-facing operational technology (OT) devices across critical infrastructures in the U.S., including programmable logic controllers (PLCs), ...

Obsidian Note Taking reshapes how information is captured, connected, and rediscovered by turning simple Markdown files into a dynamic, interconnected system. Instead of isolating notes in folders, ...

* begin to intersect at node c1. * Example 1: * Input: intersectVal = 8, listA = [4,1,8,4,5], listB = [5,0,1,8,4,5], skipA = * 2, skipB = 3 * Output: Reference of the node with value = 8 * Input ...

In the coming weeks, more than 40 drugmakers in India are expected to launch their generic versions of Novo Nordisk's semaglutide. The compound lost its patent protection in the country today.